Original Research

Published on 27 May 2024

Comparison of the safety profiles for pirfenidone and nintedanib: a disproportionality analysis of the US food and drug administration adverse event reporting system

in Pharmacoepidemiology

Xiangyu Sun
Huaguang Wang
Xi Zhan
Yuanyuan Yan
Kun Chen
Zhuoling An
Hong Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1256649

4,573 views
1 citation

Original Research

Published on 23 May 2024

Potential adverse events associated with sphingosine-1-phosphate (S1P) receptor modulators in patients with multiple sclerosis: an analysis of the FDA adverse event reporting system (FAERS) database

in Pharmacoepidemiology

Xiping Yang
Yan Yan
Suyao Liu
Zhiqing Wang
Xia Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1376494

1,991 views

Original Research

Published on 23 May 2024

Sodium-glucose cotransporter-2 inhibitors and incidence of atrial fibrillation in older adults with type 2 diabetes: a retrospective cohort analysis

in Pharmacoepidemiology

Yujia Li
Huilin Tang
Yi Guo
Hui Shao
Stephen E. Kimmel
Jiang Bian
Desmond A. Schatz
Jingchuan Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1379251

1,227 views
1 citation

Original Research

Published on 22 May 2024

COVID-19 vaccination-related tinnitus is associated with pre-vaccination metabolic disorders

in Pharmacoepidemiology

Weihua Wang
Anusha Yellamsetty
Robert M. Edmonds
Shaun R. Barcavage
Shaowen Bao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1374320

12,838 views

Original Research

Published on 13 May 2024

Post-marketing risk analysis of bendamustine: a real-world approach based on the FAERS database

in Pharmacoepidemiology

Dan Li
Yuan Zhang
Jia Qi Ni
Juan Zhu
Wen Ting Lu
Ya Lin Chen
Lei Cheng
Yu Qi Wang
Qian Jiang Li
Jie Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1372401

2,125 views

Original Research

Published on 09 May 2024

Assessing the safety of bedaquiline: insight from adverse event reporting system analysis

in Pharmacoepidemiology

Jiaqiang Wu
Hong Pan
Li Shen
Mingyi Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1382441

1,618 views

Original Research

Published on 09 May 2024

Post-marketing safety concerns with lumateperone: a pharmacovigilance analysis based on the FDA adverse event reporting system (FAERS) database

in Pharmacoepidemiology

Dan Zhao
Wangxin Zhang
Yan Liu
Zhaojun Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1389814

1,973 views
1 citation

Original Research

Published on 29 Apr 2024

Association between atorvastatin and erectile dysfunction: a comprehensive analysis incorporating real-world pharmacovigilance and Mendelian randomization

in Pharmacoepidemiology

Kaiqin Chen
Hesen Huang
Yongtai Chen
Weizhen He

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1382924

10,276 views

Original Research

Published on 24 Apr 2024

Assessment of antimicrobial prescribing patterns, guidelines compliance, and appropriateness of antimicrobial prescribing in surgical-practice units: point prevalence survey in Malaysian teaching hospitals

in Pharmacoepidemiology

Nurul Adilla Hayat Jamaluddin
Petrick Periyasamy
Chee Lan Lau
Sasheela Ponnampalavanar
Pauline Siew Mei Lai
Ly Sia Loong
Tg Mohd Ikhwan Tg Abu Bakar Sidik
Ramliza Ramli
Toh Leong Tan
Najma Kori

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1381843

2,428 views
2 citations

Perspective

Published on 18 Apr 2024

Generic orphan drug substitution: a critical analysis of global practices and Saudi Arabia’s perspective

in Pharmacoepidemiology

Yousif S. Alakeel
Emmanouil Rampakakis
Ali AlRumaih
Rana AlRuwaisan
Maha Abushal
Abdullah M. AlDalaan
Majdy M. Idrees
Zaid D. Alanazi
Hanouf AlKoait
Abdulrahman Muaadi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1376009

1,682 views

Opinion

Published on 17 Apr 2024

Sex and gender differences and pharmacovigilance: a knot still to be untied

in Pharmacoepidemiology

Liberata Sportiello
Annalisa Capuano

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1397291

1,595 views

Original Research

Published on 09 Apr 2024

A disproportionality analysis of FDA adverse event reporting system (FAERS) events for ticagrelor

in Pharmacoepidemiology

Yunyan Pan
Yu Wang
Yifan Zheng
Jie Chen
Jia Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1251961

3,280 views

Original Research

Published on 03 Apr 2024

CDK4/6 inhibitors in drug-induced liver injury: a pharmacovigilance study of the FAERS database and analysis of the drug–gene interaction network

in Pharmacoepidemiology

Youjun She
Zihan Guo
Qing Zhai
Jiyong Liu
Qiong Du
Zhongwei Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1378090

3,383 views
2 citations

Original Research

Published on 27 Mar 2024

Detection of iodixanol-induced allergic reaction signals in Chinese inpatients: a multi-center retrospective database study using prescription sequence symmetry analysis

in Pharmacoepidemiology

Dandan Zhang
Xinchen Yang
Zhangwei Yang
Wei Sun
Shunjie Chen
Lingxiao Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1298021

884 views

Original Research

Published on 15 Mar 2024

Safety assessment of cenobamate: real-world adverse event analysis from the FAERS database

in Pharmacoepidemiology

Shihao Chen
Wenqiang Fang
Linqian Zhao
Huiqin Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1369384

2,990 views
1 citation

Brief Research Report

Published on 14 Mar 2024

Prevalence of use of on-label and off-label psychotropics in the Greek pediatric population

in Pharmacoepidemiology

Stella Pesiou
Rafel Barcelo
Georgios Papazisis
Ferran Torres
Caridad Pontes

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1348887

1,536 views

Navigation group

Articles

Comparison of the safety profiles for pirfenidone and nintedanib: a disproportionality analysis of the US food and drug administration adverse event reporting system

Potential adverse events associated with sphingosine-1-phosphate (S1P) receptor modulators in patients with multiple sclerosis: an analysis of the FDA adverse event reporting system (FAERS) database

Sodium-glucose cotransporter-2 inhibitors and incidence of atrial fibrillation in older adults with type 2 diabetes: a retrospective cohort analysis

COVID-19 vaccination-related tinnitus is associated with pre-vaccination metabolic disorders

Post-marketing risk analysis of bendamustine: a real-world approach based on the FAERS database

Assessing the safety of bedaquiline: insight from adverse event reporting system analysis

Post-marketing safety concerns with lumateperone: a pharmacovigilance analysis based on the FDA adverse event reporting system (FAERS) database

Association between atorvastatin and erectile dysfunction: a comprehensive analysis incorporating real-world pharmacovigilance and Mendelian randomization

Assessment of antimicrobial prescribing patterns, guidelines compliance, and appropriateness of antimicrobial prescribing in surgical-practice units: point prevalence survey in Malaysian teaching hospitals

Generic orphan drug substitution: a critical analysis of global practices and Saudi Arabia’s perspective

Sex and gender differences and pharmacovigilance: a knot still to be untied

A disproportionality analysis of FDA adverse event reporting system (FAERS) events for ticagrelor

CDK4/6 inhibitors in drug-induced liver injury: a pharmacovigilance study of the FAERS database and analysis of the drug–gene interaction network

Detection of iodixanol-induced allergic reaction signals in Chinese inpatients: a multi-center retrospective database study using prescription sequence symmetry analysis

Safety assessment of cenobamate: real-world adverse event analysis from the FAERS database

Prevalence of use of on-label and off-label psychotropics in the Greek pediatric population